These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24680448)

  • 21. Controversies in prostate cancer staging implementation at a tertiary cancer center.
    Sexton T; Rodrigues G; Brecevic E; Boyce L; Parrack D; Lock M; D'Souza D
    Can J Urol; 2006 Dec; 13(6):3327-34. PubMed ID: 17187696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The quality of surgical pathology care for men undergoing radical prostatectomy in the U.S.
    Miller DC; Spencer BA; Shah RB; Ritchey J; Stewart AK; Gay EG; Dunn RL; Wei JT; Litwin MS
    Cancer; 2007 Jun; 109(12):2445-53. PubMed ID: 17492683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Machine learning for improved pathological staging of prostate cancer: a performance comparison on a range of classifiers.
    Regnier-Coudert O; McCall J; Lothian R; Lam T; McClinton S; N'dow J
    Artif Intell Med; 2012 May; 55(1):25-35. PubMed ID: 22206941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical practice and variation in care for childhood obesity at seven clinics in California.
    Shaikh U; Nettiksimmons J; Joseph JG; Tancredi DJ; Romano PS
    Qual Prim Care; 2012; 20(5):335-44. PubMed ID: 23114001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Practice trends in the diagnosis and management of prostate cancer in the United States.
    Gee WF; Holtgrewe HL; Albertsen PC; Litwin MS; Manyak MJ; O'Leary MP; Painter MR
    J Urol; 1995 Jul; 154(1):207-8. PubMed ID: 7539862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapies used in prostate cancer patients by European urologists: data on indication with a focus on expectations, perceived barriers and guideline compliance related to the use of bisphosphonates.
    Heidenreich A; Witjes WP; Bjerklund-Johansen TE; Patel A;
    Urol Int; 2012; 89(1):30-8. PubMed ID: 22699678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of a Statewide Oral Oncolytic Initiative on Five Participating Practices.
    Mackler E; Scappaticci GB; Salgado TM; Petersen L; Davis EJ; Peltier E; Griggs JJ; Sabo RT; Farris KB
    J Oncol Pract; 2018 May; 14(5):e304-e309. PubMed ID: 29641272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variations in quality of care for men with early-stage prostate cancer.
    Spencer BA; Miller DC; Litwin MS; Ritchey JD; Stewart AK; Dunn RL; Gay EG; Sandler HM; Wei JT
    J Clin Oncol; 2008 Aug; 26(22):3735-42. PubMed ID: 18669460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical and pathological staging of prostate cancer].
    Tobisu K
    Nihon Rinsho; 2005 Feb; 63(2):225-30. PubMed ID: 15714970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality of care indicators for prostate cancer: progress toward consensus.
    Miller DC; Saigal CS
    Urol Oncol; 2009; 27(4):427-34. PubMed ID: 19573774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Staging of prostate cancer.
    Cheng L; Montironi R; Bostwick DG; Lopez-Beltran A; Berney DM
    Histopathology; 2012 Jan; 60(1):87-117. PubMed ID: 22212080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Michigan oncology practices showed varying adherence rates to practice guidelines, but quality interventions improved care.
    Blayney DW; Severson J; Martin CJ; Kadlubek P; Ruane T; Harrison K
    Health Aff (Millwood); 2012 Apr; 31(4):718-28. PubMed ID: 22492888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Community-wide intervention to improve the attention-deficit/hyperactivity disorder assessment and treatment practices of community physicians.
    Epstein JN; Langberg JM; Lichtenstein PK; Mainwaring BA; Luzader CP; Stark LJ
    Pediatrics; 2008 Jul; 122(1):19-27. PubMed ID: 18595982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of cancer diagnosis and treatment in Medicare fee-for-service and managed care plans.
    Riley GF; Warren JL; Potosky AL; Klabunde CN; Harlan LC; Osswald MB
    Med Care; 2008 Oct; 46(10):1108-15. PubMed ID: 18815533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Staging prostate cancer.
    Hoedemaeker RF; Vis AN; Van Der Kwast TH
    Microsc Res Tech; 2000 Dec; 51(5):423-9. PubMed ID: 11074612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors associated with improvement in guideline-based use of ICDs in eligible heart failure patients.
    Mehra MR; Albert NM; Curtis AB; Gheorghiade M; Heywood JT; Liu Y; O'Connor CM; Reynolds D; Walsh MN; Yancy CW; Fonarow GC
    Pacing Clin Electrophysiol; 2012 Feb; 35(2):135-45. PubMed ID: 22145695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The process for continuous improvement of the TNM classification.
    Gospodarowicz MK; Miller D; Groome PA; Greene FL; Logan PA; Sobin LH
    Cancer; 2004 Jan; 100(1):1-5. PubMed ID: 14692017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of urologists and medical oncologists on treatment of elderly men with Stage IV prostate cancer.
    Onukwugha E; Mullins CD; Hsu VD; Seal B; Hussain A
    Urology; 2011 May; 77(5):1088-95. PubMed ID: 21439617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Peer Comparison Emails With Electronic Health Record Documentation of Cancer Stage by Oncologists.
    Sinaiko AD; Barnett ML; Gaye M; Soriano M; Mulvey T; Hochberg E
    JAMA Netw Open; 2020 Oct; 3(10):e2015935. PubMed ID: 33021649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer.
    Bunting PS; Goel V; Williams JI; Iscoe NA
    CMAJ; 1999 Jan; 160(1):70-5. PubMed ID: 9934349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.